InMed Pharmaceuticals (INM) Asset Utilization Ratio (2022 - 2025)

InMed Pharmaceuticals has reported Asset Utilization Ratio for 4 years, with the latest figure at 0.37 in Q4 2025.

• For the quarter ending Q4 2025, Asset Utilization Ratio fell 27.95% year-over-year to 0.37; the trailing twelve-month figure through Dec 2025 stood at 0.37 (down 27.95% YoY), and the FY2025 full-year result was 0.36, up 1.72% from the prior year.
• Asset Utilization Ratio for Q4 2025 stood at 0.37, up from 0.33 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 0.55 in Q1 2025, with the low at 0.1 in Q4 2022.
• Historically, Asset Utilization Ratio has averaged 0.34 across 4 years, with a median of 0.37 in 2023.
• Annual changes were most pronounced in 2023 — Asset Utilization Ratio soared 308.98% — and 2025, when it retreated 27.95%.
• InMed Pharmaceuticals' Asset Utilization Ratio stood at 0.1 in 2022, then soared by 308.98% to 0.42 in 2023, then climbed by 21.52% to 0.51 in 2024, then dropped by 27.95% to 0.37 in 2025.
• The last three Asset Utilization Ratio figures came in at 0.37 (Q4 2025), 0.33 (Q3 2025), and 0.4 (Q2 2025), per Business Quant data.